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ABSTRACT
Arthropods, such as mosquitoes and ticks, are important vectors for different viruses (so
called vector-borne viruses), some of which cause a significant number of human and animal
deaths every year as well as affect public health worldwide. Dengue virus, yellow fever virus,
chikungunya virus, Japanese encephalitis virus, tick-borne encephalitis virus and Zika virus are
just a few examples of important vector-borne viruses. The majority of all vector-borne
viruses have an RNA genome, which routinely undergo genetic modifications. The changes
in the genome, apart from the environmental issues, can also influence the spread of viruses
to new habitats and hosts and lead to the emergence of novel viruses, which may become
a threat to public health. Therefore, it is important to investigate the viruses circulating in
arthropod vectors to understand their diversity, host range and evolutionary history as well as
to predict new emerging pathogens. The choice of detection method is important, as most of
the methods can only detect viruses that have been previously well described. Viral meta-
genomics is a useful tool to simultaneously identify all the viruses present in a sample,
including novel viruses. This review describes vector-borne viruses, their maintenance and
emergence in nature, and detection using viral metagenomics.
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Introduction
Vector-borne diseases are an increasing problem
worldwide both for the human and animal popula-
tion. In fact, the World Health Organisation (WHO),
has estimated that vector-borne diseases constitute
over 17% of all human infectious diseases and cause
more than 1 million deaths yearly [1]. These diseases
are caused by different parasites, bacteria and viruses
spread between hosts (humans and/or animals) by so
called vectors. The vectors are often blood sucking
insects that transmit infectious agents by taking blood
meals. Vector-borne viruses transmitted by vectors
are often referred to as arthropod-borne viruses
(arboviruses) and are then defined as viruses that
are maintained in nature through biological transmis-
sion between susceptible vertebrate hosts by haema-
tophagous arthropods.
Mosquitoes are considered one of the primary vectors
for infectious agents, with others including ticks, biting
midges, sand-flies and flies. In humans, several mos-
quito-borne epidemics have been reported across the
globe, including the emergence of dengue fever by
Dengue virus (DENV) serotypes 1–4 transmitted by
Aedes aegypti, which is also an important vector for
other disease-causing viruses including yellow fever
virus (YFV), chikungunya virus (CHIKV), and Zika
virus (ZIKV) [2]. YFV was controlled by mosquito
abatement techniques in the Americas, but it remains
a constant threat for re-emergence in new areas byAedes
mosquitoes. ZIKV transmission occurs primarily
through bites of infected Aedes mosquitoes and has
promoted major disease outbreaks in humans [3–5].
West Nile virus (WNV) was introduced into the
Americas in 1999 and was probably a derivative of an
IsraeliWNV strain. After the introduction,WNV rapidly
spread across the United States [6]. Similarly, CHIKV
was introduced into Asia from Africa in the mid-2000s
before subsequently spreading to the Caribbean region in
2013 [7]. Rift Valley fever virus (RVFV), another medi-
cally important virus in livestock, has been identified in
different mosquito species (Aedes, Culex, Anopheles, etc.)
[8,9] and can be transmitted to humans from infected
animals. Other thanmosquitoes, several arthropods have
been identified as vectors for different pathogenic
viruses. For example, adult midges transmit BTV [10],
sand-flies are able to transmit Toscana virus, and ticks
can carry and transmit tick-borne encephalitis virus
(TBEV) and Crimean-Congo haemorrhagic fever virus
(CCHFV) [11,12], with many more vector-borne viruses
expected to be identified that affect public health. In
addition to human and animal diseases caused by vector-
borne viruses, these viruses can also affect invertebrate
health, including that of honey bees, causing serious
damage to food crops that results in huge economic
losses for the agricultural industry [13]. Dicistroviruses
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(Acute bee paralysis virus, Israeli acute bee paralysis
virus, Kashmir bee paralysis virus, etc.), iflaviruses
(Deformed wing virus (DWV), Kakugo virus and
Varroa destructor virus-1 (VDV-1), and Sacbrood virus
(SBV), etc.), and other groups of viruses have been
reported as pathogens that infect honey bee populations
in different geographical locations [14].
As shown by the examples above, vector-borne
viruses belong to a wide variety of viral families including
Flaviviridae, Phenuiviridae, Reoviridae, Togaviridae,
Rhabdoviridae and Orthomyxoviridae, Asfaviridae and
Poxviridae (Figure 1). The majority of zoonotic arbo-
viruses belong to the families Flaviviridae and
Togaviridae [15,16], and other important arboviruses
belong to the family Phenuiviridae, e.g. CCHFV and
RVFV [17,18]. Colorado tick fever virus is another
important arbovirus that belongs to the family
Reoviridae and infects humans [19]. In this review, we
will go through the general characteristics of vector-
borne viruses as well as how we can use high-
throughput sequencing to not only characterize the vir-
ome of different vectors but also discover novel viruses.
Life cycle and emergence of vector-borne
viruses
Vector-borne viruses are maintained in the environ-
ment by a complex life cycle that includes a primary
invertebrate host as well as a vertebrate host.
Transmission of viruses may be influenced by several
factors, such as the host susceptibility for the virus,
the preference of the vectors for the host and the
vector competence for a particular virus [20,21].
The majority of arboviruses are maintained through
an enzootic cycle (sylvatic cycle), where birds, rodents
or non-human primates serve as reservoir hosts
(Figure 2) and the virus transmission occurs by pri-
mary insect vectors. At the onset of viral infection,
the virus replicates in the vertebrate host to higher
titres and induces viremia. Upon feeding on this host,
an uninfected vector will become infected and after
an extrinsic incubation period, during which the
virus moves to the salivary glands and replicate to
high levels, the mosquito will be able to transmit the
virus to the next host through the saliva as it takes
a new blood meal. Viruses may also be transmitted
between vectors and domestic animals, such as pigs
and equines (epizootic/rural cycle) as well as to
humans (epidemic/urban cycle) [22]. Spill over events
of the sylvatic cycle through for example the move-
ment of humans into sylvatic habitats can trigger the
emergence of disease outbreaks in humans and
domestic animals. If the human/animal do not
develop viremia they are considered as dead-end
hosts (e.g. horses and humans in the case of WNV),
as the amplification of the virus is insufficient to
allow for arthropod vectors to become infected and
be able to transmit the virus further [23]. Some arbo-
viruses, such as DENV, CHIKV and YFV alter their
host range from non-human primates to humans,
where it amplifies and becomes able to be transmitted
to the next person by mosquitoes, leading to out-
breaks without the use of an animal reservoir [24].
During the past two decades, the incidences of
vector-borne viruses have been expanding geogra-
phically. It has been estimated that approximately
Figure 1. Classification of vector-borne viruses based on its genome characteristics. Vector-borne viruses are classified into four
different groups, represented in the different colored boxes. The boxes below represent viral families that have vector-borne
viruses within this particular group.
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50% of the world’s population is currently affected
by at least one type of vector-borne pathogen. The
diseases caused by these pathogens constitute 30%
of all emerging infectious diseases (EIDs) [25].
A combination of socio-economical, environmental
and ecological factors has contributed to the emer-
gence of novel viruses, including expanding human
population densities, deforestation, climate change,
scattering of livestock, livestock-wildlife contacts
and viral adaptation to new hosts species [26,27].
Finally, globalisation together with the complex
web of factors mentioned above, facilitates the
spread of viruses to new geographical locations,
contributing to the emergence or re-emergence of
vector-borne viruses [28].
Genetic diversity of vector-borne viruses
Vector-borne viruses comprise a genetically diverse
group of viruses that differ in the structure, composi-
tion and organisation of their genomes. This diversity
is generally not only evident between viral families
but also between individual viral species, which can
have distinctive molecular mechanisms for replica-
tion, transmission, pathogenesis and evolution [29].
The majority of vector-borne viruses contain RNA as
their genetic material (Figure 1).
Apart from ecological factors, certain genetic factors
influence the diversity and emergence of vector-borne
viruses, including: (i) the lack of proofreading activity
and repair mechanisms of the RNA-dependent RNA
polymerase (RdRP), resulting in the generation of ran-
dom insertions, deletions and substitutions (point
mutations) and new viral variants [30]; (ii) the exchange
of long stretches of genomic sequences between closely
related viruses (genetic recombination), e.g. the
Western equine encephalitis virus is a product of
recombination between the Eastern equine encephalitis
virus and a Sindbis-like virus [31,32], and in vitro stu-
dies have also shown the potential recombination
within chikungunya virus species [33]; and (iii) the
exchange of genome segments between segmented
viruses during co-infections (genetic reassortment)
that generates new genetic combinations, e.g. Thogoto
virus [34], Bluetongue virus (BTV) and Schmallenberg
virus, the latter of which may be the result of
a reassortment between Sathuperi and Shamonda
viruses [35]. Co-circulation or simultaneous infections
of different BTV serotypes can potentially generate
novel reassortant viruses [36,37].
As mentioned previously, arboviruses must be able
to infect both invertebrate and vertebrate hosts to
replicate and maintain their life cycle in nature as
such these viruses often diversify and evolve. These
variants may have the ability to alter the viral infec-
tion rate. For example, a single mutation in the
envelop glycoprotein E1 enhanced CHIKV transmis-
sion by Aedes albopictus mosquitoes, i.e. it increased
the competence of Ae. Albopictus [38] and additional
sequential mutations in CHIKV E2 increased the
infection of Ae. albopictus [39]. Viral emergence can
also be significantly influenced by viral intra-host
evolution. For example, viral sequences containing
mutations may not be identified by the RNA inter-
ference defence system (RNAi, the primary antiviral
defence mechanism in mosquitoes) [40,41]. Because
of the high genetic diversity of arboviruses, the appli-
cation of improved molecular methods may be
Figure 2. Transmission and maintenance cycles of vector-borne viruses. Arboviruses can circulate and be maintained through
the sylvatic/enzootic cycle, the epidemic/urban cycle as well as through the epizootic/rural cycle.
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required to detect novel viruses as well as to charac-
terise the viral populations, viral variants or quasis-
pecies in different arthropod vectors.
Detection of vector-borne viruses by
traditional approaches
The vast diversity of vector-borne viruses present in
nature makes their discovery and classification chal-
lenging and may require a combination of methods.
In general, the primary focus in most studies has
been the detection of pathogenic viruses that are
medically important, such as DENV, WNV, TBEV,
and CHIKV and not on other insect-borne viruses, as
many of them are asymptomatic in the vertebrate
host. The choice of detection method is based on
the known characteristics that are specific to each
virus, such as incubation period, viremia pattern
and antibody response. The identification of infection
by antibody-based serological methods is typically
used at the onset of illness or weeks after the devel-
opment of symptoms [42,43]. The classical methods
of serology include haemagglutinin inhibition and
complement fixation, and most frequently involves
the use of enzyme-linked immunosorbent assays
(ELISA) and immunofluorescence assays. Direct
detection methods that are currently available include
virus isolation, electron microscopy, molecular meth-
ods and viral antigen detection methods. Virus isola-
tion has for long been a gold standard method [44].
However, virus isolation and electron microscopy are
laborious processes, requiring a long time for viral
cultivation, which is sometimes not possible, and
requires special laboratory facilities.
Molecular detection primarily includes nucleic acid-
based amplification methods, including polymerase
chain reaction (PCR)-based methods, specifically,
reverse transcriptase (RT)-PCR-based assays, as most
vector-borne viruses are RNA viruses [45]. These
methods offer a mean of rapid viral detection during
the viremic phase and are highly sensitive [46,47].
However, some viruses produce low and short-lived
viremias, making it difficult to detect viruses such as
WNV [48]. In addition to PCR, standard molecular
methods, such as nucleic acid hybridisation methods
and microarrays, have also been used as detection
assays. All these methods are based on prior informa-
tion of viral sequences present in the sample and are
commonly species specific. Thus, the detection of
a virus is sometimes not possible if it is not known
which virus/es reside within a sample.
Viral metagenomics
Viral metagenomics is the study of the collective viral
genomes from primary samples, e.g. environmental
samples, clinical material from humans, animals and
insect tissue. This newly developed, culture- and
sequence-independent method has been able to
detect viruses behind diseases of unknown aetiology
as well as allowing the characterisation of the com-
plete viral populations in a given sample [49]. The
workflow of viral metagenomics often includes the
following steps: sample preparation, sequence-
independent amplification, high-throughput sequen-
cing, bioinformatics and follow-up studies, if neces-
sary (Figure 3) [50].
Sample preparation and amplification
Sample preparation can include a combination of
different methods that are used to enrich the virome
in the sample, including filtration, ultracentrifuga-
tion, nuclease treatment and the removal of riboso-
mal RNA. This is an important step, as the ratio of
viral nucleic acids will be much lower as compared to
the host genome [51]. Amplification of nucleic acids
can be performed by different methods, including
sequence-independent, single-primer amplification
(SISPA), which is based on the ligation of adapters
to nucleic acids [52]. SISPA has been combined with
random PCR and nuclease treatment steps [53–56] to
amplify divergent viral sequences present in the sam-
ple. Random PCR (rPCR) [57], linker-amplified shot-
gun library (LASL) [58], single-primer isothermal
amplification (SPIA) [59] and multiple displacement
amplification (MDA), the latter of which uses the
displacement DNA polymerase, e.g. the phi29 DNA
polymerase [60], are other amplification methods that
have been used. Although these methods have been
successfully used to amplify the metagenomes, they
have some limitations, such as an incomplete retrieval
of viral genomes, an amplification bias towards the 3ʹ
end of the genomes and a biased distribution of
sequencing depth [59,61,62].
High-throughput sequencing
A combination of Sanger sequencing and advanced
fluorescent detection methods led to the development
of next generation sequencing (NGS), often referred to
as second-generation sequencing. The first high-
throughput sequencing platform (HTS) was intro-
duced in 2005, which was 454 pyrosequencing by
454 Life Sciences (acquired by Roche in 2007 and
later shut down in 2013). Several HTS platforms have
been developed over the years that feature variable
read lengths, type of sequencing, run times and
throughput capacity [63]. The cost of sequencing for
each reaction has been significantly reduced in recent
years, and sequencing machines are able to generate
massive sequence outputs, up to 1500 Gb. The
Illumina method is based on a paired-end read chem-
istry and has numerous platforms (HiSeq, MiSeq, and
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NextSeq), each with different read lengths and run
times while producing high-throughput data. Ion-
torrent (from Life technologies) runs as a single-read
platform and was the first semiconductor-based plat-
form that could generate up to 1 Gb of data, with
a longer read lengths of up to 400 bases. The newer
versions, Ion proton and Ion S5, can generate up to
15 Gb of data with varying read lengths. The latest
HTS platforms from Pacific Bio and Oxford Nanopore
have been developed to generate longer sequences of
up to 200 Kb. The choice of sequencing platform
depends on the application, and each platform has it
strengths and weaknesses. The benchtop instruments
developed by Illumina and Ion Torrent have been
largely used in various insect virome sequencing pro-
jects [64–68]. Table 1 summarises the HTS platforms
available and their sequencing features.
Bioinformatics
Bioinformatics is the application of tools and compu-
tational analyses to understand and interpret biologi-
cal data. Bioinformatics is an interdisciplinary field
that has been widely applied in modern biology and
Table 1. Summary of high-throughput sequencing (HTS) technologies available, the detection method, their output read
length, throughput, and runtime. Information has been obtained from the sequencing company webpages. (PE: paired-end,
SE: single-end, Kb, kilobase pairs, Mb: megabase pairs, Gb: gigabase pairs, Tb: terabase pairs, M: millions, B: billions, h: hours,
NA: not available).
Platform Detection method Read length Throughput Reads Runtime
Short-read sequencing
Illumina MiniSeq Sequencing by Synthesis 150 (PE) 7.5 Gb 44–50 M 24 h
Illumina MiSeq Sequencing by Synthesis 300 (PE) 13–15 Gb 44–50 M 21–56 h
Illumina NextSeq Sequencing by Synthesis 150 (PE) 100–120 Gb 800 M 29 h
Illumina HiSeq Sequencing by Synthesis 150 (PE) 650–750 Gb 2.5 B 1–3.5 d
Ion Torrent Semiconductor Sequencing 400 (SE) 1–2 Gb 4–5.5 M 7.3 h
Ion Proton Semiconductor Sequencing 200 (SE) Up to 10 Gb 60–80 M 2–4 h
Ion S5 Semiconductor Sequencing 200 (SE) 10–15 Gb 60–80 M 2.5 h
Long-read sequencing
Pacific Bio Single–molecule real-time Sequencing 20 Kb 500 Mb–1 Gb ~55,000 4 h
Pacific Bio Sequel Single–molecule real-time Sequencing 8–12 Kb 3.5–7 Gb ~350,000 0.5–6 h
Oxford Nanopore MinION Nanopore DNA sequencing Up to 200 Kb 40 Gb >100,000 48 h
Oxford Nanopore PromethION (48 flow cells) Nanopore DNA sequencing Up to 200 Kb Up to 15 Tb NA 64 h
Figure 3. General workflow of viral metagenomics. Most viral metagenomics studies includes the following steps: sample
preparation, sequence-independent amplification, high-throughput sequencing, bioinformatics in order to identify the viruses
present in the samples.
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medicine for data management [69]. The analysis of
massive sequencing data generated from HTS plat-
forms typically includes quality checking, assembly
and taxonomic classification of reads and/or contigs
produced by the assembly (Figure 4).
Quality checking involves trimming of sequences
according to Phred quality scores, which are related
to base calling error probabilities [70]. It also
includes, identifying and removing sequence dupli-
cates that are produced by the HTS platform as
a result of PCR amplification, PCR errors or sequen-
cing errors and is necessary to reduce the computa-
tional time, to accurately calculate an estimated
species abundance and to improve the assembly. All
these quality filtering conditions can be specified
depending on the downstream analyses required
[71,72]. Moreover, the sequences that are not
a target of the study can be filtered out to eliminate
misassemblies and to speed up the analysis. For
example, the host sequences can be removed from
a sample if the target sequences are viral-related reads
[73]. Possible contaminating sequences or sequences
that are not relevant can also be removed by aligning
against reference sequences, which can be performed
using several short reads alignment tools such as
BWA, SOAP2 and Bowtie2 [74–76].
The assembly of shorter sequences that have match-
ing overlaps generates longer sequences called contig-
uous sequences (contigs), a method referred to as de
novo assembly. These contigs can be further extended
by merging shorter contigs. There are two primary
types of de novo assembly programmes, Overlap/
Layout/Consensus assemblers (e.g. MIRA, Celera, and
VICUNA), which are widely used for longer reads [77]
and de Bruijn graph assemblers (e.g. Velvet, SOAP de
novo, SPAdes) [78–80]. However, the assembly process
might generate ‘chimeric’ sequences involving the
assembly of sequences from different organisms or
species, which may be a problem in viral metagenomic
studies as the biological sample may contain closely
related viral sequences [81].
Taxonomic classification is the final step in the
metagenomic analysis, where each sequence is
assigned to a taxonomic group. The most commonly
used similarity-based classification is Basic Local
Alignment Search Tool (BLAST) [82], where the
sequences are compared to known genomes.
Different versions of BLAST can be used, such as
BLASTx and tBLASTx [83,84]. Considering the time
span for sequence classification, several different tools
have been developed that can reduce the time
required from weeks to days, e.g. RAPsearch2,
Diamond, Kaiju and Kraken [85–88].
Viral metagenomics provide basic information on
which viruses are present in a sample. More extensive
analysis or follow-up studies are necessary to under-
stand the roles of the identified virus/viruses. These
analyses may include obtaining full-length viral gen-
omes by the primer walking approach, RACE analysis,
virus isolation, viral characterisation and developing
diagnostic assays, which all depends on the objective
of the study [50,89].
Bioinformatics challenges in analysing viral
metagenomes
Despite the development of advanced computational
tools to analyse viral sequences from mixed samples,
several bottlenecks are restricting effective data ana-
lysis. For example, the tools may require expertise
and computational resources for users to be able to
access them. Building longer contigs by assembling
shorter reads can sometimes be problematic because
of the high viral diversity in the sample. Closely
related viral genomes can be mapped to supplied
reference genome through reference-based assembly,
which is computationally efficient, however, diver-
gent viral genomes cannot be aligned by this
approach. Another method, de novo assembly, used
Figure 4. Bioinformatic workflow for viral metagenomics. The
main bioinformatics steps used to analyse the HTS sequen-
cing data sets.
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for reconstruction of full-length genomes may gen-
erate ambiguous or chimeric sequences due to muta-
tions and recombination of closely related viruses
[90]. The de novo assembly process generates com-
plex assembly graphs and fragmented assemblies,
which are computationally demanding. One of the
most important issues in metagenomic studies is
sequence classification, which mainly depends on
the similarity between the query sequence and anno-
tated genomes in the database. Classification pro-
grams based on nucleotide alignments are
sometimes not sensitive enough in detecting diver-
gent viral sequences while protein searches may be
slower and require powerful computers or highly
optimized tools (e.g. Diamond and Kaiju).
Customized databases, such as those only with viral
genomes, can be used for similarity searches, how-
ever, it may result in misclassification of sequences.
Limited representation of viral sequences in the
curated sequence databases is another challenge in
classifying novel viruses as reads that originate from
viruses may be unclassified due to that relative viral
sequences are not present in the database [91].
Implications of invertebrate viromes in
human and animal public health
With the use of metagenomics and transcriptomics,
a broad range of unknown and highly divergent
RNA viruses have been discovered from different
invertebrate species. For example, a meta-
transcriptomics analysis of 220 invertebrate species
resulted in the discovery of 1445 RNA viruses,
including probable new viral families [92]. In
another study, 112 novel RNA viruses were
reported from 70 arthropod species [93]. These
studies show that invertebrates harbour RNA
viruses with greater genetic diversity than pre-
viously expected, and that some of the identified
viruses are likely to be ancestors of major viral
groups, including those that infect vertebrates.
Thus, analysing the biodiversity of invertebrate vir-
omes may have important implications for our
understanding of virus evolution, ecology and
emergence. An advantage using this approach is
also that we detect not only arboviruses but also
viruses that are restricted to insect hosts (insect-
specific viruses, ISVs). These types of viruses are
interesting as evolutionary relationships show that
these viruses are related to arboviruses, and that
some of the ISVs may been ancestral to pathogenic
arboviruses [94,95]. Also, different studies have
reported that some of these ISVs are able to reduce
the replication of certain arboviruses following pre-
infection or coinfection [96–98].
Thus. the complex pattern of multiple viruses
and the large number of completely new ones in
the same sample poses a considerable challenge for
the scientific community to bring this in order so
we can understand their role in disease and health.
Such as, what is their function in the host and do
they cooperate in some way? A practical issue to
solve before we can understand this is to individu-
ally isolate them as virus particles. We need to
cultivate them in order to study their respectively
biological properties. From previous experience, we
know that many of the viruses are not possible, or
very difficult, to cultivate in cell cultures. Also, how
can we ensure that they are pure from other viruses
once we cultured them? To address this difficult
task, we may initially use a classical virus cultiva-
tion strategy using various cells and plaque purify
them. It is however likely that many will not be able
to be cultivated and purified this way. An alterna-
tive approach could be to construct full-length
infectious clones of the viruses we discover simply
by synthetizing their genomes and insert them into
suitable vectors, transfect these and then recover the
viruses. This approach has been used successfully
with a variety of different virus families [99,100].
The very large DNA viruses may however need
another approach by amplification of the genome
and subcloning parts and them assemble them as
full-length genomes into the vector. By this strategy
it would be possible to recover and isolate indivi-
dual viruses and then study their properties. Such
as what receptors do they use, their tropism, repli-
cation strategies, how do they invade the innate
immunity and what type of CPE (if any) are typical
for them and so on. This knowledge is important in
order to go on and study what type of animals they
can infect and their role in disease of animals and
humans, including their mode of action.
Acknowledgments
This study was financially supported by the Swedish
Research council (VR) (SWE-2012-138; 2016-01251) and
the SLU vice chancellor career support awarded to Assoc.
Prof. Anne-Lie Blomström. As well as the Swedish
Research council for Environment, Agricultural Sciences
and Spatial planning, FORMAS (SWE-2012-586), awarded
to Prof. Mikael Berg.
Disclosure statement
No potential conflict of interest was reported by the
authors.
Funding
This work was supported by the Svenska Forskningsrådet
Formas [2012-586]; Sveriges Lantbruksuniversitet [2016-
junior-career-support-ALB]; Vetenskapsrådet [2016-01251];
Vetenskapsrådet [2012-138].
INFECTION ECOLOGY & EPIDEMIOLOGY 7
Notes on contributors
Harindranath Cholleti, he received bachelor degree in
Biotechnology from Jawaharlal Nehru Technological
University, India and MSc degree from Uppsala
University. He obtained his PhD from Swedish University
of Agricultural Sciences, Sweden.
Mikael Berg, he received his bachelor degree in
Microbiology at Uppsala University, Sweden. He is specia-
lized in Veterinary Virology, and obtained his PhD from
Swedish University of Agricultural Sciences. He is currently
Professor in Veterinary Virology at the Department of
Biomedical Sciences and Veterinary Public Health,
Swedish University of Agricultural Science, Sweden.
Juliette Hayer, she received master degree in
Bioinformatics, Structural Biochemistry and Genomics
and a PhD in Bioinformatics. She is currently a researcher
at the Department of Animal Breeding and Genetics,
Swedish University of Agricultural Sciences, Sweden.
Anne-Lie Blomström, she received her master degree in
Biology andPhD from the Swedish University of
Agricultural Sciences. She is currently a researcher and
Associate Professor in Molecular Virology at the
Department of Biomedical Sciences and Veterinary Public
Health, Swedish University of Agricultural Sciences, Sweden.
ORCID
Mikael Berg http://orcid.org/0000-0001-5779-3345
Juliette Hayer http://orcid.org/0000-0003-4899-9637
References
[1] WHO. A global brief on vector-borne diseases.
Geneva: World Health Organization; 2014.
[2] Gratz NG. Emerging and resurging vector-borne
diseases. Annu Rev Entomol. 1999;44:51–75. Epub
1999/02/17. PubMed PMID: 9990716.
[3] Ryan SJ, Carlson CJ, Stewart-Ibarra AM, et al.
Outbreak of Zika virus infections, Dominica, 2016.
Emerg Infect Dis. 2017;23(11):1926–1927. Epub
2017/10/20. PubMed PMID: 29048289; PubMed
Central PMCID: PMCPMC5652428.
[4] Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread
of emerging Zika virus in the Pacific area. Clin
Microbiol Infect. 2014;20(10):595–596. Epub 2014/
06/10. PubMed PMID: 24909208.
[5] Duffy MR, Chen TH, Hancock WT, et al. Zika virus
outbreak on Yap Island, federated states of
micronesia. N Engl J Med. 2009;360(24):2536–2543.
Epub 2009/06/12. PubMed PMID: 19516034.
[6] Lanciotti RS, Roehrig JT, Deubel V, et al. Origin of
the West Nile virus responsible for an outbreak of
encephalitis in the northeastern United States.
Science. 1999;286(5448):2333–2337. Epub 1999/ 12/
22.PubMed PMID: 10600742.
[7] Burt FJ, ChenW,Miner JJ, et al. Chikungunya virus: an
update on the biology and pathogenesis of this emer-
ging pathogen. Lancet Infect Dis. 2017;17(4):e107–e17.
Epub 2017/02/06. PubMed PMID: 28159534.
[8] Grobbelaar AA, Weyer J, Leman PA, et al.
Molecular epidemiology of rift valley fever virus.
Emerg Infect Dis. 2011;17(12):2270–2276. Epub
2011/12/17. PubMed PMID: 22172568; PubMed
Central PMCID: PMCPMC3311189.
[9] Tantely LM, Boyer S, Fontenille D. A review of mosqui-
toes associated with rift valley fever virus inMadagascar.
Am J Trop Med Hyg. 2015;92(4):722–729. Epub 2015/
03/04. PubMed PMID: 25732680; PubMed Central
PMCID: PMCPMC4385764.
[10] Brand SP, Keeling MJ. The impact of temperature
changes on vector-borne disease transmission:
culicoides midges and bluetongue virus. J R Soc
Interface. 2017;14(128). Epub 2017/03/17. PubMed
PMID: 28298609; PubMed Central PMCID:
PMCPMC5378124. DOI:10.1098/rsif.2016.0481
[11] Charrel RN, Gallian P, Navarro-Mari JM, et al.
Emergence of toscana virus in Europe. Emerg
Infect Dis. 2005;11(11):1657–1663. Epub 2005/12/
02. PubMed PMID: 16318715; PubMed Central
PMCID: PMCPMC3367371.
[12] Mansfield KL, Jizhou L, Phipps LP, et al. Emerging
tick-borne viruses in the twenty-first century. Front
Cell Infect Microbiol. 2017;7:298. Epub 2017/07/27.
PubMed PMID: 28744449; PubMed Central PMCID:
PMCPMC5504652.
[13] Brutscher LM, McMenamin AJ, Flenniken ML. The
buzz about honey bee viruses. PLoS Pathog. 2016;12(8):
e1005757. Epub 2016/08/19. PubMed PMID: 27537076;
PubMed Central PMCID: PMCPMC4990335.
[14] Chen YP, Siede R. Honey bee viruses. Adv Virus Res.
2007;70:33–80. Epub 2007/09/04. PubMed PMID:
17765703.
[15] Dobler G. Zoonotic tick-borne flaviviruses. Vet
Microbiol. 2010;140(3–4):221–228. Epub 2009/ 09/
22. PubMed PMID: 19765917.
[16] Kurkela S, Ratti O, Huhtamo E, et al. Sindbis virus
infection in resident birds, migratory birds, and
humans, Finland. Emerg Infect Dis. 2008;14(1):41–47.
Epub 2008/02/09. PubMed PMID: 18258075; PubMed
Central PMCID: PMCPMC2600146.
[17] Hoogstraal H. The epidemiology of tick-borne
Crimean-Congo hemorrhagic fever in Asia, Europe,
and Africa. J Med Entomol. 1979;15(4):307–417.
Epub 1979/05/22. PubMed PMID: 113533.
[18] Pepin M, Bouloy M, Bird BH, et al. Rift valley fever
virus(Bunyaviridae: Phlebovirus): an update on
pathogenesis, molecular epidemiology, vectors, diag-
nostics and prevention. Vet Res. 2010;41(6):61. Epub
2010/ 12/29.PubMed PMID: 21188836; PubMed
Central PMCID: PMCPMC2896810.
[19] Calisher CH, Poland JD, Calisher SB, et al. Diagnosis of
Colorado tick fever virus infection by enzyme immu-
noassays for immunoglobulin M and G antibodies.
J Clin Microbiol. 1985;22(1):84–88. Epub 1985/07/01.
PubMed PMID: 2991332; PubMed Central PMCID:
PMCPMC268327.
[20] Lambrechts L, Scott TW. Mode of transmission and
the evolution of arbovirus virulence in mosquito
vectors. Proc Biol Sci. 2009;276(1660):1369–1378.
Epub 2009/ 01/15. PubMed PMID: 19141420;
PubMed Central PMCID: PMCPMC2660968.
[21] Carver S, Bestall A, Jardine A, et al. Influence of hosts
on the ecology of arboviral transmission: potential
mechanisms influencing dengue, Murray Valley ence-
phalitis, and Ross River virus in Australia. Vector
Borne Zoonotic Dis. 2009;9(1):51–64. Epub 2008/
09/20. PubMed PMID: 18800866.
[22] Weaver SC, Barrett AD. Transmission cycles, host
range, evolution and emergence of arboviral disease.
8 H. CHOLLETI ET AL.
Nat Rev Microbiol. 2004;2(10):789–801. Epub 2004/
09/21. PubMed PMID: 15378043.
[23] Gubler DJ. Human arbovirus infections worldwide.
Ann N Y Acad Sci. 2001;951:13–24. Epub 2002/ 01/
19.PubMed PMID: 11797771.
[24] Weaver SC, Reisen WK. Present and future arboviral
threats. Antiviral Res. 2010;85(2):328–345. Epub
2009/ 10/28. PubMed PMID: 19857523; PubMed
Central PMCID: PMCPMC2815176.
[25] Jones KE, Patel NG, Levy MA, et al. Global trends in
emerging infectious diseases. Nature. 2008;451
(7181):990–993. Epub 2008/ 02/22. PubMed PMID:
18288193.
[26] Morens DM, Folkers GK, Fauci AS. The challenge of
emerging and re-emerging infectious diseases.
Nature. 2004;430(6996):242–249. Epub 2004/ 07/09.
PubMed PMID: 15241422.
[27] Pfeffer M, Dobler G. Emergence of zoonotic arboviruses
by animal trade and migration. Parasit Vectors. 2010;3
(1):35. Epub 2010/04/10. PubMed PMID: 20377873;
PubMed Central PMCID: PMCPMC2868497.
[28] Simon F, Savini H, Parola P. Chikungunya:
a paradigm of emergence and globalization of
vector-borne diseases. Med Clin North Am. 2008;92
(6):1323–1343, ix. Epub 2008/ 12/09. PubMed PMID:
19061754.
[29] Gray SM, Banerjee N. Mechanisms of arthropod
transmission of plant and animal viruses. Microbiol
Mol Biol Rev. 1999;63(1):128–148. Epub 1999/03/06.
PubMed PMID: 10066833; PubMed Central PMCID:
PMCPMC98959.
[30] Drake JW, Holland JJ. Mutation rates among RNA
viruses. Proc Natl Acad Sci U S A. 1999;96
(24):13910–13913. Epub 1999/11/26.PubMed PMID:
10570172; PubMed Central PMCID: PMCPMC24164.
[31] Weaver SC, Kang W, Shirako Y, et al. Recombinational
history andmolecular evolution of western equine ence-
phalomyelitis complex alphaviruses. J Virol. 1997;
71(1):613–623. Epub 1997/01/01.PubMed PMID:
8985391; PubMed Central PMCID: PMCPMC191092.
[32] Hahn CS, Lustig S, Strauss EG, et al. Western equine
encephalitis virus is a recombinant virus. Proc Natl
Acad Sci U S A. 1988;85(16):5997–6001. Epub 1988/
08/01. PubMed PMID: 3413072; PubMed Central
PMCID: PMCPMC281892.
[33] He CQ, Ding NZ, He M, et al. Intragenic recombina-
tion as a mechanism of genetic diversity in bluetongue
virus. J Virol. 2010;84(21):11487–11495. Epub 2010/
08/13. PubMed PMID: 20702614; PubMed Central
PMCID: PMCPMC2953192.
[34] Davies CR, Jones LD, Green BM, et al. In vivo reas-
sortment of Thogoto virus (a tick-borne influenza-like
virus) following oral infection of Rhipicephalus
appendiculatus ticks. J Gen Virol. 1987;68(Pt
9):2331–2338. Epub 1987/09/01. PubMed PMID:
3655743.
[35] Yanase T, Kato T, Aizawa M, et al. Genetic reassort-
ment between Sathuperi and Shamonda viruses of
the genus Orthobunyavirus in nature: implications
for their genetic relationship to Schmallenberg virus.
Arch Virol. 2012;157(8):1611–1616. Epub 2012/ 05/
17. PubMed PMID: 22588368.
[36] Shafiq M, Minakshi P, Bhateja A, et al. Evidence of
genetic reassortment between Indian isolate of blueton-
gue virus serotype 21 (BTV-21) and bluetongue virus
serotype 16 (BTV-16). Virus Res. 2013;173(2):336–343.
Epub 2013/ 01/29. PubMed PMID: 23353779.
[37] Maan S,MaanNS, GuimeraM, et al. Genome sequence
of a reassortant strain of bluetongue virus serotype 23
from western India. J Virol. 2012;86(12):7011–7012.
Epub 2012/05/26. PubMed PMID: 22628397; PubMed
Central PMCID: PMCPMC3393570.
[38] Tsetsarkin KA, Vanlandingham DL, McGee CE, et al.
A single mutation in chikungunya virus affects vector
specificity and epidemic potential. PLoS Pathog. 2007;3
(12):e201. Epub 2007/12/12. PubMed PMID: 18069894;
PubMed Central PMCID: PMCPMC2134949.
[39] Tsetsarkin KA, Weaver SC. Sequential adaptive
mutations enhance efficient vector switching by
Chikungunya virus and its epidemic emergence.
PLoS Pathog. 2011;7(12):e1002412. Epub 2011/12/
17. PubMed PMID: 22174678; PubMed Central
PMCID: PMCPMC3234230.
[40] Brackney DE, Beane JE, Ebel GD. RNAi targeting of
West Nile virus in mosquito midguts promotes virus
diversification. PLoS Pathog. 2009;5(7):e1000502.
Epub 2009/07/07. PubMed PMID: 19578437;
PubMed Central PMCID: PMCPMC2698148.
[41] Brackney DE, Schirtzinger EE, Harrison TD, et al.
Modulation of flavivirus population diversity by
RNA interference. J Virol. 2015;89(7):4035–4039.
Epub 2015/01/30. PubMed PMID: 25631077;
PubMed Central PMCID: PMCPMC4403385.
[42] Gubler DJ, Kuno G, Sather GE, et al. Mosquito cell
cultures and specific monoclonal antibodies in surveil-
lance for dengue viruses. Am J Trop Med Hyg. 1984;33
(1):158–165. Epub 1984/01/01.PubMed PMID: 6364855.
[43] Innis BL, Nisalak A, Nimmannitya S, et al. An
enzyme-linked immunosorbent assay to characterize
dengue infections where dengue and Japanese encepha-
litis co-circulate. Am J Trop Med Hyg. 1989;40
(4):418–427. Epub 1989/04/01.PubMed PMID: 2540664.
[44] Leland DS, Ginocchio CC. Role of cell culture for
virus detection in the age of technology. Clin
Microbiol Rev. 2007;20(1):49–78. Epub 2007/01/16.
PubMed PMID: 17223623; PubMed Central PMCID:
PMCPMC1797634.
[45] Tanaka M. Rapid identification of flavivirus using the
polymerase chain reaction. J Virol Methods. 1993;41
(3):311–322. Epub 1993/03/01.PubMed PMID: 8097200.
[46] Lanciotti RS, Kerst AJ, Nasci RS, et al. Rapid detec-
tion of west nile virus from human clinical speci-
mens, field-collected mosquitoes, and avian samples
by a TaqMan reverse transcriptase-PCR assay. J Clin
Microbiol. 2000;38(11):4066–4071. Epub 2000/11/04.
PubMed PMID: 11060069; PubMed Central PMCID:
PMCPMC87542.
[47] Lanciotti RS, Kerst AJ. Nucleic acid sequence-based
amplification assays for rapid detection of West
Nile and St. Louis encephalitis viruses. J Clin
Microbiol. 2001;39(12):4506–4513. Epub 2001/11/
29. PubMed PMID: 11724870; PubMed Central
PMCID: PMCPMC88574.
[48] Murray KO, Walker C, Gould E. The virology, epide-
miology, and clinical impact ofWest Nile virus: a decade
of advancements in research since its introduction
into the Western Hemisphere. Epidemiol Infect.
2011;139(6):807–817. Epub 2011/02/24. PubMed
PMID: 21342610.
[49] Delwart EL. Viral metagenomics. Rev Med Virol.
2007;17(2):115–131. Epub 2007/ 02/14. PubMed
PMID: 17295196.
[50] Blomstrom AL. Viral metagenomics as an emerging
and powerful tool in veterinary medicine. Vet Q.
INFECTION ECOLOGY & EPIDEMIOLOGY 9
2011;31(3):107–114. Epub 2011/10/28. PubMed
PMID: 22029881.
[51] Hall RJ, Wang J, Todd AK, et al. Evaluation of rapid
and simple techniques for the enrichment of viruses
prior to metagenomic virus discovery. J Virol
Methods. 2014;195:194–204. Epub 2013/ 09/17.
PubMed PMID: 24036074.
[52] ReyesGR,Kim JP. Sequence-independent, single-primer
amplification (SISPA) of complex DNA populations.
Mol Cell Probes. 1991;5(6):473–481. Epub 1991/ 12/01.
PubMed PMID: 1664049.
[53] Allander T, Emerson SU, Engle RE, et al. A virus
discovery method incorporating DNase treatment
and its application to the identification of two bovine
parvovirus species. Proc Natl Acad Sci U S A. 2001;98
(20):11609–11614. Epub 2001/09/20. PubMed PMID:
11562506; PubMed Central PMCID: PMCPMC58777.
[54] Froussard P. rPCR: a powerful tool for random ampli-
fication of whole RNA sequences. PCR Methods Appl.
1993;2(3):185–190. Epub 1993/ 02/01.PubMed PMID:
7680262.
[55] Djikeng A, Halpin R, Kuzmickas R, et al. Viral
genome sequencing by random priming methods.
BMC Genomics. 2008;9:5. Epub 2008/01/09.
PubMed PMID: 18179705; PubMed Central
PMCID: PMCPMC2254600.
[56] van der Hoek L, Pyrc K, Jebbink MF, et al.
Identification of a new human coronavirus. Nat
Med. 2004;10(4):368–373. Epub 2004/03/23. PubMed
PMID: 15034574.
[57] Froussard P. A random-PCR method (rPCR) to con-
struct whole cDNA library from low amounts of
RNA. Nucleic Acids Res. 1992;20(11):2900. Epub
1992/ 06/11. PubMed PMID: 1614887; PubMed
Central PMCID: PMCPMC336952.
[58] Breitbart M, Salamon P, Andresen B, et al. Genomic
analysis of uncultured marine viral communities. Proc
Natl Acad Sci U S A. 2002;99(22):14250–14255. Epub
2002/10/18. PubMed PMID: 12384570; PubMed
Central PMCID: PMCPMC137870.
[59] Myrmel M, Oma V, Khatri M, et al. Single primer
isothermal amplification (SPIA) combined with next
generation sequencing provides complete bovine coro-
navirus genome coverage and higher sequence depth
compared to sequence-independent single prim-
er amplification (SISPA). PLoS One. 2017;12(11):
e0187780. Epub 2017/ 11/08. PubMed PMID:
29112950; PubMed Central PMCID: PMCPMC
5675387.
[60] Dean FB, Hosono S, Fang L, et al. Comprehensive
human genome amplification using multiple displa-
cement amplification. Proc Natl Acad Sci U S A.
2002;99(8):5261–5266. Epub 2002/04/18. PubMed
PMID: 11959976; PubMed Central PMCID:
PMCPMC122757.
[61] Rosseel T, Ozhelvaci O, Freimanis G, et al.
Evaluation of convenient pretreatment protocols for
RNA virus metagenomics in serum and tissue
samples. J Virol Methods. 2015;222:72–80. Epub
2015/05/31. PubMed PMID: 26025457.
[62] Karlsson OE, Belak S, Granberg F. The effect of pre-
processing by sequence-independent, single-primer
amplification (SISPA) on metagenomic detection of
viruses. Biosecur Bioterror. 2013;11(Suppl 1):S227–
S234. Epub 2013/ 11/06. PubMed PMID: 23971810.
[63] Goodwin S, McPherson JD, McCombie WR. Coming
of age: ten years of next-generation sequencing
technologies. Nat Rev Genet. 2016;17(6):333–351.
Epub 2016/05/18. PubMed PMID: 27184599.
[64] Liu S, Vijayendran D, Bonning BC. Next generation
sequencing technologies for insect virus discovery.
Viruses. 2011;3(10):1849–1869. Epub 2011/11/10.
PubMed PMID: 22069519; PubMed Central PMCID:
PMCPMC3205385.
[65] Frey KG, Biser T, Hamilton T, et al. Bioinformatic
characterization of mosquito viromes within the east-
ern United States and Puerto Rico: discovery of Novel
viruses. Evol BioinformOnline. 2016;12(Suppl 2):1–12.
Epub 2016/ 06/28. PubMed PMID: 27346944; PubMed
Central PMCID: PMCPMC4912310.
[66] Pettersson JH, Shi M, Bohlin J, et al. Characterizing
the virome of Ixodes ricinus ticks from northern
Europe. Sci Rep. 2017;7(1):10870. Epub 2017/09/09.
PubMed PMID: 28883464; PubMed Central PMCID:
PMCPMC5589870.
[67] Xia H, Hu C, Zhang D, et al. Metagenomic profile of
the viral communities in Rhipicephalus spp. ticks from
Yunnan, China. PLoS One. 2015;10(3):e0121609. Epub
2015/03/24. PubMed PMID: 25799057; PubMed
Central PMCID: PMCPMC4370414.
[68] Cholleti H, Hayer J, Abilio AP, et al. Discovery of
Novel viruses in mosquitoes from the Zambezi
Valley of Mozambique. PLoS One. 2016;11(9):
e0162751. PubMed PMID: 27682810; PubMed
Central PMCID: PMCPMC5040392.
[69] Bayat A. Science, medicine, and the future:
bioinformatics. BMJ. 2002;324(7344):1018–1022.
Epub 2002/ 04/27. PubMed PMID: 11976246;
PubMed Central PMCID: PMCPMC1122955.
[70] Ewing B, Green P. Base-calling of automated sequen-
cer traces using phred. II. Error probabilities.
Genome Res. 1998;8(3):186–194. Epub 1998/05/16.
PubMed PMID: 9521922.
[71] Bokulich NA, Subramanian S, Faith JJ, et al. Quality-
filtering vastly improves diversity estimates from
Illumina amplicon sequencing. Nat Methods. 2013;10
(1):57–59. Epub 2012/ 12/04. PubMed PMID: 23202435;
PubMed Central PMCID: PMCPMC3531572.
[72] Patel RK, Jain M. NGS QC toolkit: a toolkit for
quality control of next generation sequencing data.
PLoS One. 2012;7(2):e30619. Epub 2012/ 02/09.
PubMed PMID: 22312429; PubMed Central
PMCID: PMCPMC3270013.
[73] Bzhalava D, Johansson H, Ekstrom J, et al.
Unbiased approach for virus detection in skin
lesions. PLoS One. 2013;8(6):e65953. Epub 2013/
07/11. PubMed PMID: 23840382; PubMed Central
PMCID: PMCPMC3696016.
[74] Li H, Durbin R. Fast and accurate long-read alignment
with Burrows-Wheeler transform. Bioinformat-
ics. 2010;26(5):589–595. Epub 2010/01/19. PubMed
PMID: 20080505; PubMed Central PMCID:
PMCPMC2828108.
[75] Li R, Yu C, Li Y, et al. SOAP2: an improved ultrafast
tool for short read alignment. Bioinformatics.
2009;25(15):1966–1967. Epub 2009/ 06/06. PubMed
PMID: 19497933.
[76] Langmead B, Salzberg SL. Fast gapped-read alignment
with bowtie 2. Nat Methods. 2012;9(4):357–359. Epub
2012/03/06. PubMed PMID: 22388286; PubMed
Central PMCID: PMCPMC3322381.
[77] Yang X, Charlebois P, Gnerre S, et al. De novo
assembly of highly diverse viral populations. BMC
Genomics. 2012;13:475. Epub 2012/09/15. PubMed
10 H. CHOLLETI ET AL.
PMID: 22974120; PubMed Central PMCID:
PMCPMC3469330.
[78] Zerbino DR. Using the velvet de novo assembler for
short-read sequencing technologies. Curr Protoc
Bioinformatics. 2010; Chapter 11: Unit11 5. Epub
2010/09/14. PubMed PMID: 20836074; PubMed
Central PMCID: PMCPMC2952100. DOI:10.1002/
0471250953.bi1105s31
[79] Luo R, Liu B, Xie Y, et al. SOAPdenovo2: an empiri-
cally improved memory-efficient short-read de novo
assembler. Gigascience. 2012;1(1):18. Epub 2012/ 01/
01. PubMed PMID: 23587118; PubMed Central
PMCID: PMCPMC3626529.
[80] Bankevich A, Nurk S, Antipov D, et al. SPAdes: a new
genome assembly algorithm and its applications to
single-cell sequencing. J Comput Biol. 2012;19(5):455–
477. Epub 2012/ 04/18. PubMed PMID: 22506599;
PubMed Central PMCID: PMCPMC3342519.
[81] Berthet N, Descorps-Declere S, Nkili-Meyong AA,
et al. Improved assembly procedure of viral RNA
genomes amplified with Phi29 polymerase from
new generation sequencing data. Biol Res. 2016;49
(1):39. Epub 2016/09/09. PubMed PMID: 27605096;
PubMed Central PMCID: PMCPMC5015205.
[82] Altschul SF, Gish W, Miller W, et al. Basic local
alignment search tool. J Mol Biol. 1990;215
(3):403–410. Epub 1990/10/05. PubMed PMID:
2231712.
[83] Gish W, States DJ. Identification of protein coding
regions by database similarity search. Nat Genet.
1993;3(3):266–272. Epub 1993/03/01. PubMed
PMID: 8485583.
[84] McGinnis S, Madden TL. BLAST: at the core of
a powerful and diverse set of sequence analysis tools.
Nucleic Acids Res. 2004;32(Web Server issue):W20–
W25. Epub 2004/ 06/25. PubMed PMID: 15215342;
PubMed Central PMCID: PMCPMC441573.
[85] Zhao Y, Tang H, Ye Y. RAPSearch2: a fast and
memory-efficient protein similarity search tool for
next-generation sequencing data. Bioinformatics.
2012;28(1):125–126. Epub 2011/ 11/01. PubMed
PMID: 22039206; PubMed Central PMCID:
PMCPMC3244761.
[86] Buchfink B, Xie C, Huson DH. Fast and sensitive
protein alignment using DIAMOND. Nat Methods.
2015;12(1):59–60. Epub 2014/ 11/18. PubMed PMID:
25402007.
[87] Menzel P, Ng KL, Krogh A. Fast and sensitive taxo-
nomic classification for metagenomics with Kaiju. Nat
Commun. 2016;7:11257. PubMed PMID: 27071849;
PubMed Central PMCID: PMCPMC4833860.
[88] Wood DE, Salzberg SL. Kraken: ultrafast metagenomic
sequence classification using exact alignments. Genome
Biol. 2014;15(3):R46. PubMed PMID: 24580807;
PubMed Central PMCID: PMCPMC4053813.
[89] Rosseel T, Pardon B, De Clercq K, et al. False-
positive results in metagenomic virus discovery:
a strong case for follow-up diagnosis. Transbound
Emerg Dis. 2014;61(4):293–299. Epub 2014/ 06/11.
PubMed PMID: 24912559.
[90] Domingo E, Sheldon J, Perales C. Viral quasispecies
evolution. Microbiol Mol Biol Rev. 2012;76(2):159–216.
Epub 2012/06/13. PubMed PMID: 22688811; PubMed
Central PMCID: PMCPMC3372249.
[91] Simmonds P. Methods for virus classification and the
challenge of incorporating metagenomic sequence
data. J Gen Virol. 2015;96(Pt 6):1193–1206. Epub
2015/06/13. PubMed PMID: 26068186.
[92] Shi M, Lin XD, Tian JH, et al. Redefining the inver-
tebrate RNA virosphere. Nature. 2016. Epub 2016/
11/24. PubMed PMID: 27880757. DOI:10.1038/
nature20167
[93] Li CX, Shi M, Tian JH, et al. Unprecedented genomic
diversity of RNA viruses in arthropods reveals the ances-
try of negative-sense RNA viruses. Elife. 2015;4. Epub
2015/01/31. PubMed PMID: 25633976; PubMedCentral
PMCID: PMCPMC4384744. DOI:10.7554/eLife.05378
[94] Bolling BG, Weaver SC, Tesh RB, et al. Insect-
specific virus discovery: significance for the arbovirus
community. Viruses. 2015;7(9):4911–4928. Epub
2015/ 09/18. PubMed PMID: 26378568; PubMed
Central PMCID: PMCPMC4584295.
[95] Marklewitz M, Zirkel F, Kurth A, et al. Evolutionary
and phenotypic analysis of live virus isolates suggests
arthropod origin of a pathogenic RNA virus family.
Proc Natl Acad Sci U S A. 2015;112(24):7536–7541.
PubMed PMID: 26038576; PubMed Central PMCID:
PMCPMC4475995.
[96] Kuwata R, Isawa H, Hoshino K, et al. Analysis of
mosquito-borne flavivirus superinfection in culex
tritaeniorhynchus (Diptera: Culicidae) cells persis-
tently infected with culex flavivirus (Flaviviridae).
J Med Entomol. 2015;52(2):222–229. Epub 2015/
09/04. PubMed PMID: 26336307.
[97] Hobson-Peters J, Yam AW, Lu JW, et al. A new
insect-specific flavivirus from northern Australia
suppresses replication of West Nile virus and
Murray Valley encephalitis virus in co-infected mos-
quito cells. PLoS One. 2013;8(2):e56534. Epub 2013/
03/06. PubMed PMID: 23460804; PubMed Central
PMCID: PMCPMC3584062.
[98] Kenney JL, Solberg OD, Langevin SA, et al.
Characterization of a novel insect-specific flavivirus
from Brazil: potential for inhibition of infection of
arthropod cells with medically important
flaviviruses. J Gen Virol. 2014;95(Pt 12):2796–2808.
Epub 2014/ 08/26. PubMed PMID: 25146007;
PubMed Central PMCID: PMCPMC4582674.
[99] Atieh T, El Ayoubi MD, Aubry F, et al. Haiku: new
paradigm for the reverse genetics of emerging RNA
viruses. PLoS One. 2018;13(2):e0193069. PubMed
PMID: 29438402; PubMed Central PMCID:
PMCPMC5811033.
[100] Lowen AC, Noonan C, McLees A, et al. Efficient
bunyavirus rescue from cloned cDNA. Virology.
2004;330(2):493–500. PubMed PMID: 15567443.
INFECTION ECOLOGY & EPIDEMIOLOGY 11
